| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| KIOVIG 100mg/ml | IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA | SOL. PERF. | J06BA02 | W66549005 | TAKEDA MANUFACTURING AUSTRIA AG - AUSTRIA | X | |||||
| KIOVIG 100mg/ml | IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA | SOL. PERF. | J06BA02 | W66549006 | TAKEDA MANUFACTURING AUSTRIA AG - AUSTRIA | X | |||||
| KINPEYGO 4 mg | BUDESONIDUM | CAPS. CU ELIB. MODIF. | A07EA06 | W69385001 | STADA ARZNEIMITTEL AG - GERMANIA | X | |||||
| KINPEYGO 4 mg | BUDESONIDUM | CAPS. CU ELIB. MODIF. | A07EA06 | W69385002 | STADA ARZNEIMITTEL AG - GERMANIA | X | |||||
| KINPARLEV 8 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71942001 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 8 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71942002 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 8 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71942003 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 8 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71942004 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 8 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71942005 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 6 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71941001 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 6 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71941002 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 6 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71941003 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 6 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71941004 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 6 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71941005 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 4 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71940001 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 4 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71940002 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 4 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71940003 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 4 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71940004 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 4 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71940005 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 3 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71939001 | ORION CORPORATION - FINLANDA |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman